Park, S.-H.; Kang, I.-C.; Hong, S.-S.; Kim, H.-Y.; Hwang, H.-K.; Kang, C.-M.
Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study. Cancers 2024, 16, 1844.
https://doi.org/10.3390/cancers16101844
AMA Style
Park S-H, Kang I-C, Hong S-S, Kim H-Y, Hwang H-K, Kang C-M.
Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study. Cancers. 2024; 16(10):1844.
https://doi.org/10.3390/cancers16101844
Chicago/Turabian Style
Park, Su-Hyeong, In-Cheon Kang, Seung-Soo Hong, Ha-Yan Kim, Ho-Kyoung Hwang, and Chang-Moo Kang.
2024. "Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study" Cancers 16, no. 10: 1844.
https://doi.org/10.3390/cancers16101844
APA Style
Park, S.-H., Kang, I.-C., Hong, S.-S., Kim, H.-Y., Hwang, H.-K., & Kang, C.-M.
(2024). Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study. Cancers, 16(10), 1844.
https://doi.org/10.3390/cancers16101844